| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/29/1999 | EP0966973A1 Sorbefacients |
| 12/29/1999 | EP0966968A1 Therapeutic combinations comprising a selective estrogen receptor modulator and prostaglandin E2 |
| 12/29/1999 | EP0966967A2 Combination therapy of olanzapine (zyprexa) and fluoxetine (prozac) for treatment of bipolar disorder |
| 12/29/1999 | EP0966966A2 Nefazodone dosage form |
| 12/29/1999 | EP0966965A1 Methods for reducing levels of homocysteine and C-reactive protein |
| 12/29/1999 | EP0966964A1 Methods for increasing levels of acetylcholine |
| 12/29/1999 | EP0966963A1 Use of indigoid bisindole derivatives as CDK1 inhibitors |
| 12/29/1999 | EP0966962A1 Modafinil having defined particle size |
| 12/29/1999 | EP0966961A1 Method for controlling ectoparasites |
| 12/29/1999 | EP0966960A1 Agent for inhibiting carcinogenesis or tumor metastasis |
| 12/29/1999 | EP0966958A1 Aerosol preparation |
| 12/29/1999 | EP0966537A2 AN $i(EX VIVO) ANIMAL OR CHALLENGE MODEL AS METHOD TO MEASURE PROTECTIVE IMMUNITY DIRECTED AGAINST PARASITES AND VACCINES SHOWN TO BE PROTECTIVE IN SAID METHOD |
| 12/29/1999 | EP0966536A1 Factor x analogues with a modified protease cleavage site |
| 12/29/1999 | EP0966534A1 Compositions and methods for elimination of unwanted cells |
| 12/29/1999 | EP0966532A1 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same |
| 12/29/1999 | EP0966525A1 Method of using tetracycline compounds for inhibition of nitric oxide production |
| 12/29/1999 | EP0966511A2 Washing disinfectant for hygienic and surgical hand disinfection |
| 12/29/1999 | EP0966486A2 Method for producing regular porous cellulose pearls, corresponding cellulose pearls and use thereof |
| 12/29/1999 | EP0966484A1 Neurotactin and uses therefor |
| 12/29/1999 | EP0966480A2 Cysteine-depleted peptides recognized by a3-restricted cytotoxic lymphocytes, and uses therefor |
| 12/29/1999 | EP0966476A1 Quinazolinone compounds |
| 12/29/1999 | EP0966473A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 12/29/1999 | EP0966472A1 Cephalosporin derivatives |
| 12/29/1999 | EP0966471A1 2-beta-substituted-6-alkylidene penicillanic acid derivatives as beta-lactamase inhibitors |
| 12/29/1999 | EP0966470A1 Dioxino derivatives and their use as therapeutic agents |
| 12/29/1999 | EP0966466A1 PYRROLO 3,2-c]QUINOLINE DERIVATIVES CONTAINING HALOALKOXY GROUP AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF |
| 12/29/1999 | EP0966465A1 Inhibitors of impdh enzyme |
| 12/29/1999 | EP0966464A1 Substituted 2,4-diaminopyrimidines |
| 12/29/1999 | EP0966463A1 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid |
| 12/29/1999 | EP0966462A1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| 12/29/1999 | EP0966460A1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| 12/29/1999 | EP0966457A1 Ring opening metathesis of alkenes |
| 12/29/1999 | EP0966456A1 Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof |
| 12/29/1999 | EP0966455A1 Oxiran carboxylic acids for the treatment of diabetes |
| 12/29/1999 | EP0966454A1 Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 12/29/1999 | EP0966448A1 Pyrazine compounds |
| 12/29/1999 | EP0966447A1 Small molecules useful in the treatment of inflammatory disease |
| 12/29/1999 | EP0966446A1 Bicyclic inhibitors of protein farnesyl transferase |
| 12/29/1999 | EP0966443A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 12/29/1999 | EP0966442A1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity |
| 12/29/1999 | EP0966439A1 Certain cyclic thio substituted acylaminoacid amide derivatives |
| 12/29/1999 | EP0966438A1 N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases |
| 12/29/1999 | EP0966437A1 5-aroylnaphthalene derivatives |
| 12/29/1999 | EP0966436A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 12/29/1999 | EP0966435A1 Aminoindan derivatives |
| 12/29/1999 | EP0966434A1 Aminophenol derivatives and their use in cosmetics |
| 12/29/1999 | EP0966431A1 Salicylic acid-sphingoid base derivatives and uses thereof |
| 12/29/1999 | EP0966430A1 Anti-inflammatory compounds |
| 12/29/1999 | EP0966427A1 Preparation of acid amides and metallisation of compounds |
| 12/29/1999 | EP0966426A1 Novel diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them |
| 12/29/1999 | EP0966424A1 Aminobenzophenones as inhibitors of interleukin and tnf |
| 12/29/1999 | EP0966423A1 Hydroxymethyl derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene as cardiovascular agent |
| 12/29/1999 | EP0966303A2 Polypeptide conjugates for transporting substances across cell membranes |
| 12/29/1999 | EP0966295A1 Calcareous material |
| 12/29/1999 | EP0966289A1 Budesonide for the treatment of cholestatic liver diseases |
| 12/29/1999 | EP0966288A1 Androgen as a male contraceptive and non-contraceptive androgen replacement |
| 12/29/1999 | EP0966287A1 Oxacarbazepine film-coated tablets |
| 12/29/1999 | EP0966286A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
| 12/29/1999 | EP0966285A1 Use of (+)mefloquine for the treatment of malaria |
| 12/29/1999 | EP0966284A1 Starter kit containing nicotinic acid compositions |
| 12/29/1999 | EP0966283A2 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells |
| 12/29/1999 | EP0966282A1 Use of angiotensin ii antagonists to treat symptomatic heart failure |
| 12/29/1999 | EP0966281A1 2-phenyl-3-azoylbenzothiophene for lowering intraocular pressure |
| 12/29/1999 | EP0966280A1 Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemo- and radiotherapy |
| 12/29/1999 | EP0966279A1 Ascorbic acid as an adjuvant in the removal of vascular occlusions |
| 12/29/1999 | EP0966278A1 Oral compositions containing zinc citrate salts |
| 12/29/1999 | EP0966277A1 Use of r-nsaid's for the prevention of alzheimer's disease |
| 12/29/1999 | EP0966276A1 Use of agonists of adrenergic beta-3 receptors for preparing wound-healing medicines |
| 12/29/1999 | EP0966275A1 Composition of a dietary product that is effective to combat oxidative stress and cell decay |
| 12/29/1999 | EP0966274A2 Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase |
| 12/29/1999 | EP0966272A1 Improved dosage units |
| 12/29/1999 | EP0966269A1 Immediate release drug delivery forms |
| 12/29/1999 | EP0966266A1 Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof |
| 12/29/1999 | EP0966257A1 Barrier to plaque formation |
| 12/29/1999 | EP0966256A1 Agents for promoting oral hygiene and oral health |
| 12/29/1999 | EP0966245A2 Antimicrobial cosmetic compositions |
| 12/29/1999 | EP0966209A1 Cooked cereal ingredient-containing products fortified with edta/iron compositions and methods for use |
| 12/29/1999 | EP0966196A1 Composition for organ cryopreservation and treatment of viral and bacterial infections |
| 12/29/1999 | EP0938477A4 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 12/29/1999 | EP0868716A4 Method for recovering data from disk with magneto-resistive head in presence of thermal asperities |
| 12/29/1999 | EP0813412B1 Gel for the local hormonotherapy of vaginal dryness |
| 12/29/1999 | EP0785932B1 Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists |
| 12/29/1999 | EP0774005B1 Surface expression of enzyme in gene directed prodrug therapy |
| 12/29/1999 | EP0751788B1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug |
| 12/29/1999 | EP0677514B1 Cyclopropyl derivatives, preparation method thereof and applications |
| 12/29/1999 | EP0668781B1 Lymphokine gene therapy of cancer in combination with tumor antigens |
| 12/29/1999 | EP0654031B1 Stereoselective synthesis of nucleoside analogues using bicyclic intermediate |
| 12/29/1999 | EP0612314B1 2-pyrazinylethylamine derivatives and their use as pharmaceuticals |
| 12/29/1999 | EP0556292B1 Hepatitis c virus asialoglycoproteins |
| 12/29/1999 | EP0379483B1 1,2,3,4,10,14b-HEXAHYDRODIBENZO c,f]PYRAZINO- 1,2-a]AZEPINO DERIVATIVES |
| 12/29/1999 | CN1239998A Lactobacillus bifidus growth promoting composition and use thereof |
| 12/29/1999 | CN1239977A Stable aqueous dispersions and stable water-dispersible dry xanthophyll powder, their production and use |
| 12/29/1999 | CN1239967A 8(9)-dehydroestradiol derivatives |
| 12/29/1999 | CN1239966A Novel erythromycin derivatives, method for preparing them and their use as medicine |
| 12/29/1999 | CN1239964A Tetraphosphonate bicyclic trisanhydrides |
| 12/29/1999 | CN1239962A 1,4-diazabicyclo [2,2,2] oct-2-ylmethyl derivatives, their preparation and therapeutic application |
| 12/29/1999 | CN1239961A Pharmaceutically active tricyclic amines |
| 12/29/1999 | CN1239959A Subsitutted 2(2,6-dioxopiperidin-3-yl) phthalimides and -1-xoisoindolines and method of reducing TNF-alpha levels |
| 12/29/1999 | CN1239952A 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors |
| 12/29/1999 | CN1239951A Novel substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them |